Figures & data
Figure 1 Classification of LLCs.
Table 1 Materials used to prepare LLCs
Figure 2 (A) The mesophases of LLC: i, lamellar phase; ii, hexagonal phase; iii, micellar cubic phase – bcc; iv, micellar cubic phase – fcc (different colors represent the three-dimensional arrangement of the same molecules present in the micellar cubic phases); v, primitive bicontinuous cubic phase; vi, double diamond bicontinuous cubic phase; vii, gyroid bicontinuous cubic phase. (B) Schematic of self-assembly structures corresponding to CPP values. P stands for CPP values. V is the hydrophobic tail volume, a is the hydrophilic head group area and l is the hydrophobic tail length. (C) Possible localization of drugs in the following: i, reverse hexagonal phase; ii, reverse bicontinuous cubic phase (double diamond); iii, reverse bicontinuous cubic phase (primitive).
Table 2 Micelle shape corresponding to CPP values
Table 3 Bragg peak ratios for LLCs
Table 4 Recent reports of liquid crystalline systems
Figure 3 Drug solubilization within the small intestine.
Abbreviations: BS, bile salt; DG, diglycerol; FA, fatty acids; LC, liquid crystal; MG, monoglycerol; PL, phospholipid.
Figure 4 Transdermal drug delivery using LCs.
Abbreviations: LC, liquid crystal; SC, stratum corneum.
